Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT®

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 11, 2016

Primary Completion Date

December 22, 2022

Study Completion Date

December 22, 2022

Conditions
Hemophilia AHemophiliaFactor VIII Deficiency
Interventions
DRUG

octocog alfa

Pharmacokinetic Characterization of the Hemophilia A Population in Spain using an standalone web-based software

DRUG

rurioctocog alfa pegol

Pharmacokinetic Characterization of the Hemophilia A Population in Spain using an standalone web-based software

Trial Locations (14)

15006

Complexo Hospitalario Universitario A Coruña, A Coruña

28046

Hospital Universitario La Paz, Madrid

29010

Hospital Regional Universitario de Málaga, Málaga

29011

Hospital Materno-infantil de Málaga, Málaga

30120

Hospital Universitario Virgen de la Arrixaca, El Palmar

31008

Hospital Virgen del Camino, Pamplona

33011

Hospital Universitario Central de Asturias, Oviedo

36212

Hospital Xeral de Vigo, Vigo

41013

Hospital Universitario Virgen del Rocío, Seville

46026

Hospital Universitari i Politècnic La Fe, Valencia

48903

Hospital Universitario Cruces, Barakaldo

07120

Hospital Universitario Son Espases, Palma

08950

Hospital Sant Joan de Deu, Esplugues de Llobregat

08035

Hospital Vall D'Hebron, Barcelona

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

collaborator

Instituto de Investigación Hospital Universitario La Paz

OTHER

lead

Spanish Society of Thrombosis and Haemostasis

OTHER